# Treatment of Coronary In-Stent Restenosis

Study · id `cardio:ct-nct01735825` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01735825](<https://clinicaltrials.gov/study/NCT01735825>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01735825

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.

## Technical summary

Registry record NCT01735825. Randomized; double masking; primary purpose treatment. Start 2012-01 (actual); primary completion 2015-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 199 participants (enrolled count; ClinicalTrials.gov record NCT01735825, source copy `cardio:ctgov-nct01735825-2022-12-08`, retrieved 2026-10-26)
- Started: 2012-01 (actual) (ClinicalTrials.gov record NCT01735825, source copy `cardio:ctgov-nct01735825-2022-12-08`, retrieved 2026-10-26)
- Primary completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01735825, source copy `cardio:ctgov-nct01735825-2022-12-08`, retrieved 2026-10-26)
- Completion: 2018-06 (actual) (ClinicalTrials.gov record NCT01735825, source copy `cardio:ctgov-nct01735825-2022-12-08`, retrieved 2026-10-26)
- Countries: Czechia (ClinicalTrials.gov record NCT01735825, source copy `cardio:ctgov-nct01735825-2022-12-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01735825-2022-12-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Treatment of Coronary In-Stent Restenosis
- Acronym: TIS
- Condition: Restenosis
- Intervention (Device): paclitaxel-coated balloon catheter with Iopromide coating
- Intervention (Device): drug eluting stent with everolimus
- Intervention (Device): seal-wing paclitaxel-eluting balloon catheter
- Lead sponsor: University Hospital Ostrava
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: University Hospital Ostrava (`cardio:org-university-hospital-ostrava`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study (`cardio:pubmed-27069104`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study (`cardio:pubmed-30019843`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9b0cad623a327999f4ae75f4166478ccf6a84c4edbf03f582504fe29fa2fd4e1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
